These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 33771932)
1. Understanding commercial actors' engagement in policy debates on proposed e-cigarette regulation in Scotland. Ikegwuonu T; Hilton S; Smith KE; Buckton CH; Wong M; Weishaar HB Tob Control; 2022 Jul; 31(4):511-519. PubMed ID: 33771932 [TBL] [Abstract][Full Text] [Related]
2. E-Cigarettes: A Disruptive Technology? An Analysis of Health Actors' Positions on E-Cigarette Regulation in Scotland. Weishaar HB; Ikegwuonu T; Smith KE; Buckton CH; Hilton S Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31455009 [TBL] [Abstract][Full Text] [Related]
3. Evidence use in E-cigarettes debates: scientific showdowns in a 'wild west' of research. Smith KE; Ikegwuonu T; Weishaar H; Hilton S BMC Public Health; 2021 Feb; 21(1):362. PubMed ID: 33593318 [TBL] [Abstract][Full Text] [Related]
4. Unpacking commercial sector opposition to European smoke-free policy: lack of unity, 'fear of association' and harm reduction debates. Weishaar H; Amos A; Collin J Tob Control; 2016 Jul; 25(4):422-9. PubMed ID: 26055268 [TBL] [Abstract][Full Text] [Related]
5. 'It will harm business and increase illicit trade': an evaluation of the relevance, quality and transparency of evidence submitted by transnational tobacco companies to the UK consultation on standardised packaging 2012. Evans-Reeves KA; Hatchard JL; Gilmore AB Tob Control; 2015 Jun; 24(e2):e168-77. PubMed ID: 25472733 [TBL] [Abstract][Full Text] [Related]
6. Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool. Ralston R; Hil SE; da Silva Gomes F; Collin J Int J Health Policy Manag; 2021 Mar; 10(5):255-265. PubMed ID: 32610752 [TBL] [Abstract][Full Text] [Related]
7. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations. Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604 [TBL] [Abstract][Full Text] [Related]
8. An analysis of key stakeholder policy perspectives in the proposed e-cigarette regulations in New Zealand. Hardie L; McCool J; Freeman B Health Promot J Austr; 2023 Oct; 34(4):875-882. PubMed ID: 36843364 [TBL] [Abstract][Full Text] [Related]
9. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials. Peeters S; Gilmore AB PLoS Med; 2013; 10(9):e1001506. PubMed ID: 24058299 [TBL] [Abstract][Full Text] [Related]
10. Transnational Tobacco Companies and New Nicotine Delivery Systems. Mathers A; Hawkins B; Lee K Am J Public Health; 2019 Feb; 109(2):227-235. PubMed ID: 30571303 [TBL] [Abstract][Full Text] [Related]
11. Representation and misrepresentation of scientific evidence in contemporary tobacco regulation: a review of tobacco industry submissions to the UK Government consultation on standardised packaging. Ulucanlar S; Fooks GJ; Hatchard JL; Gilmore AB PLoS Med; 2014 Mar; 11(3):e1001629. PubMed ID: 24667150 [TBL] [Abstract][Full Text] [Related]
12. Change in tobacco excise policy in Bulgaria: the role of tobacco industry lobbying and smuggling. Skafida V; Silver KE; Rechel BP; Gilmore AB Tob Control; 2014 May; 23(e1):e75-84. PubMed ID: 23143869 [TBL] [Abstract][Full Text] [Related]
13. From transit hub to major supplier of illicit cigarettes to Argentina and Brazil: the changing role of domestic production and transnational tobacco companies in Paraguay between 1960 and 2003. Iglesias RM; Gomis B; Carrillo Botero N; Shepherd P; Lee K Global Health; 2018 Nov; 14(1):111. PubMed ID: 30454015 [TBL] [Abstract][Full Text] [Related]
14. Can't see the woods for the trees: exploring the range and connection of tobacco industry argumentation in the 2012 UK standardised packaging consultation. Lie JLY; Fooks G; de Vries NK; Heijndijk SM; Willemsen MC Tob Control; 2018 Jul; 27(4):448-454. PubMed ID: 28743794 [TBL] [Abstract][Full Text] [Related]
15. Tobacco industry messaging around harm: Narrative framing in PMI and BAT press releases and annual reports 2011 to 2021. Fitzpatrick I; Dance S; Silver K; Violini M; Hird TR Front Public Health; 2022; 10():958354. PubMed ID: 36330126 [TBL] [Abstract][Full Text] [Related]
16. Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control. Weishaar H; Collin J; Smith K; GrĂ¼ning T; Mandal S; Gilmore A PLoS Med; 2012; 9(6):e1001249. PubMed ID: 22745607 [TBL] [Abstract][Full Text] [Related]
17. How to combat efforts to overturn bans on electronic nicotine delivery systems: lessons from tobacco industry efforts during the 1980s to open closed cigarette markets in Thailand. Patanavanich R; Glantz SA BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33500264 [TBL] [Abstract][Full Text] [Related]
18. 'Maybe they should regulate them quite strictly until they know the true dangers': a focus group study exploring UK adolescents' views on e-cigarette regulation. Weishaar H; Trevisan F; Hilton S Addiction; 2016 Sep; 111(9):1637-45. PubMed ID: 26948979 [TBL] [Abstract][Full Text] [Related]
19. The challenges in protecting public health interests in multisectoral governance in the context of small island developing states: the case of tobacco control in Fiji and Vanuatu. Patay D; Schram A; Friel S Global Health; 2023 Apr; 19(1):31. PubMed ID: 37118741 [TBL] [Abstract][Full Text] [Related]
20. Examining Twitter Discourse on Electronic Cigarette and Tobacco Consumption During National Cancer Prevention Month in 2018: Topic Modeling and Geospatial Analysis. Lu J; Lee EWJ J Med Internet Res; 2021 Dec; 23(12):e28042. PubMed ID: 34964716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]